Sign in

As local Durham businesses endured the pandemic, many experienced empty storefronts and stagnant sales. To preserve their physical and fiscal safety, businesses have started to close, leading to hundreds of lost jobs and high levels of anxiety for employers and employees. Greenlight Durham has sought to mitigate this problem for businesses through providing access to coordinated symptom monitoring, testing, and recovery services to help businesses continue to operate safely financially and physically.

Our Phase 1 Work

Through our app, small business employees have been able to ‘check-in’ daily and get access to information about medical and social services including access to Curamericas community health…


Building Vaccine Confidence Through Intentional Community Engagement

Greenlight Ready, a start-up in Durham, brings together clinical, technical, and community health expertise to support the Durham and North Carolina community during this pandemic. Among its activities are providing communities with information about the COVID-19 vaccine, empowering community leaders to speak about vaccinations with their community members, and addressing concerns while increasing vaccine confidence. As North Carolina continues the COVID-19 vaccine rollout, public health messaging and vaccine education are critical to getting everyone vaccinated as quickly, safely and equitably as possible.

Public health experts stress the importance of vaccination to help protect against COVID-19. In addition to other COVID-19…


A few weeks ago, I had my first shift volunteering as a vaccinator at a local COVID-19 vaccine clinic. I realized halfway through my shift that nearly everyone I had vaccinated was white. I looked up from my station — only a smattering of people of color within sight. The one Black person I vaccinated that morning was a retired physician.

The demographic data for vaccinated people in North Carolina is shocking. The vaccination rate among the white population is 2.4 times that of the rate among Black individuals — 8.0% versus 3.4%. Otherwise put, though Black people make up…


The Greenlight Model for Defense

As the COVID-19 pandemic continues to rage on, the operations of small businesses and schools have been disrupted. At Greenlight, we offer tools and practices that minimize risk of COVID-19 transmission by creating many layers of defense that protect operating facilities and their communities. You can visualize these layers of defense as Swiss cheese slices. Like a Swiss cheese slice, no single layer of protection is perfect and has some holes in it. However, when we stack these efforts together, similar to slices of Swiss cheese, we become better protected against COVID-19 infection . …


Summaries from new articles and research papers exploring COVID-19, disparities, schools, novel treatments, and prevention strategies for 10/26/20–11/1/20.

Greenlight’s weekly research roundups are brought to you through our partnership with the Pandemic Response Network.

Empower your community with Greenlight’s COVID 19 monitoring and social support.

Executive Summary

Remdesivir was approved by the Food and Drug Administration (FDA) as a treatment in patients hospitalized with COVID-19. Tocilizumab was not shown to have therapeutic benefit in reducing clinical worsening in patients hospitalized with COVID-19. Scientists indicated that transmission of SARS-CoV-2 from surfaces and objects was not a significant form of transmission. Obesity was identified…


Executive Summary

Summaries from new articles and research papers exploring COVID-19, disparities, schools, novel treatments, and prevention strategies for 9/26/20–10/2/20.

Greenlight’s weekly deep dives our brought to you through our partnership with the Pandemic Response Network.

Researchers are searching for better pooling and testing strategies which are more cost-effective, accurate, and have faster turn around rates. All the while, New York City and many college campuses just experienced an uptick of cases, raising concerns about opening up schools. School districts are still struggling to balance the fear of outbreaks and the challenges of providing the best mode of instruction to their students…


Summaries from new articles and research papers exploring COVID-19, disparities, schools, novel treatments, and prevention strategies for 9/19/20–9/25/20.

Greenlight’s weekly deep dives our brought to you through our partnership with the Pandemic Response Network.

Executive Summary

Johnson & Johnson and Novavax have begun Phase 3 clinical trials on their vaccine candidates. There are still no clinical trials of COVID-19 vaccine candidates in children. Auto-antibodies to type I interferons were shown to partially explain severe COVID-19 and some of the gender disparity in severe disease course. Risk for X-linked recessive traits in males over females may explain such differences. Statins were found to…


Summaries from new articles and research papers exploring COVID-19, disparities, schools, novel treatments, and prevention strategies for 9/12/20–9/18/20.

Greenlight’s weekly deep dives our brought to you through our partnership with the Pandemic Response Network.

Overview

  1. Executive Summary
  2. Important Statistics/Quotes
  3. COVID-19 & the Education System
  4. Disparities Among Race, Ethnicity, & Geography
  5. Infection Prevention and Treatment Strategies
  6. The Race for a Vaccine
  7. Infection Rates and Disease Course in Children
  8. Live Trackers/Important Links

Executive Summary

Pfizer and Moderna released their clinical trial protocols under pressure by researchers for increased transparency. Astrazeneca resumed their COVID-19 vaccine trial after one participant developed a serious inflammatory condition. U.S. hospitals…


Summaries from new articles and research papers exploring COVID-19, disparities, schools, novel treatments, and prevention strategies for 10/26/20–11/1/20.

Greenlight’s weekly research roundups are brought to you through our partnership with the Pandemic Response Network.

Empower your community with Greenlight’s COVID 19 monitoring and social support.

Overview

  1. Executive Summary
  2. Important Statistics/Quotes
  3. COVID-19 & the Education System
  4. Disparities Among Race, Ethnicity, & Geography
  5. Infection Prevention and Treatment Strategies
  6. The Race for a Vaccine
  7. Infection Rates and Disease Course in Children
  8. Live Trackers/Important Links

Executive Summary

An editorial from the Lancet summarized what is currently known about routes of transmission of SARS-CoV-2 and what risk mitigation…


Summaries from new articles and research papers exploring COVID-19, disparities, schools, novel treatments, and prevention strategies for 9/12/20–9/18/20.

Greenlight’s weekly research roundups are brought to you through our partnership with the Pandemic Response Network.

Executive Summary

Pediatric COVID-19 updates from this week include further characterization of racial and ethnic disparities in COVID-19 infection rates, lack of available COVID-19 diagnostic testing for children, and lack of inclusion of children and racial and ethnic minorities in clinical trials of COVID-19 vaccines and therapeutics. Concerns for vaccine approval and rollout after approval continue to abound, as President Trump continues to push for rapid COVID-19 therapeutic…

Greenlight

All the information you need to stay safe and reopen.

Get the Medium app

A button that says 'Download on the App Store', and if clicked it will lead you to the iOS App store
A button that says 'Get it on, Google Play', and if clicked it will lead you to the Google Play store